Clinical trial · Interventional
The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction
NCT05424666CI-TRIAL-00059186unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Role of Lipofilling After Oncoplastic Breast surgeries : Evaluation of Outcomes and Patient Satisfaction
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Breast | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Harvesting method and Fat graft preparation method | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patient going Oncoplastic Breast surgeries
- description
- Lipofilling After Oncoplastic Breast surgeries : Evaluation of Outcomes and Patient Satisfaction
- interventionNames
- Procedure: Harvesting method and Fat graft preparation method
Primary outcomes (1)
- measure
- Cosmetic apperance
- timeFrame
- 1 week
- description
- Volumetric evaluation of breast after surgery and symmetry to the other breast
Secondary outcomes (1)
- measure
- Complications during the treatment and follow up
- timeFrame
- 1 month
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: Female gender. Age of 18 years and older. History or in candidate for a mastectomy in the near future. Patients undergoing prophylactic mastectomy. Patients' choice to undergo a breast reconstruction. Wanting to participate in this study. Patient is able to wear the BRAVA (BRA like VAcuum-based external tissue expander) device. Exclusion Criteria: Active smoker or a history of smoking 4 weeks prior to surgery. Current substance abuse. History of lidocaine allergy. Four weeks or less after chemotherapy. History of radiation therapy in the breast region. Oncological treatment includes radiotherapy after mastectomy. Kidney disease. Steroid dependent (daily or weekly). Immune-suppressed or immune-compromised disease. Uncontrolled diabetes. body mass index of \>30. Large breast size (ie, larger than cup C), unless the patient prefers reduction of the contralateral side towards cup C. Extracapsular silicone leaking from the encapsulated implant from a previous breast reconstruction.
References
Publications (0)
Data not yet available
No reference posted for this study.